Japan Ophthalmic Viscoelastic Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Cohesive OVD and Dispersive OVD), By Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplant, and Vitreoretinal Surgery), and Japan Ophthalmic Viscoelastic Devices Market Insights, Industry Trend, Forecasts to 2033

Industry: Healthcare

RELEASE DATE Apr 2025
REPORT ID SI10005
PAGES 215
REPORT FORMAT PathSoft

Japan Ophthalmic Viscoelastic Devices Market Insights Forecasts to 2033

  • The Japan Ophthalmic Viscoelastic Devices Market Size was valued at USD 0.17 Billion in 2023.
  • The Market Size is Growing at a CAGR of 5.12% from 2023 to 2033
  • The Japan Ophthalmic Viscoelastic Devices Market Size is Expected to Reach USD 0.28 Billion by 2033

Japan Ophthalmic Viscoelastic Devices Market

Get more details on this report -

Request Free Sample PDF

The Japan Ophthalmic Viscoelastic Devices Market Size is Anticipated to Reach USD 0.28 Billion by 2033, Growing at a CAGR of 5.12% from 2023 to 2033.

 

Market Overview

Japan ophthalmic viscoelastic devices market refers to the segment of the medical Devices industry that produces and distributes viscoelastic substances used during ophthalmic surgeries, such as cataract or glaucoma procedures. These devices, which include substances like sodium hyaluronate, are essential for maintaining eye shape and protecting delicate structures during surgery. Additionally, advancements in OVD technology, such as the development of higher viscosity formulations and bio-compatible materials, have further fueled market expansion. The Japanese government has been supportive of the medical Devices sector through various initiatives, including the promotion of advanced healthcare technology under the Health and Medical Strategy. In addition, there are several reimbursement schemes that help make ophthalmic surgeries more affordable for the aging population, driving demand for such devices. Regulatory frameworks and technological investments have been designed to foster innovation while ensuring high patient safety standards, positioning Japan as a leading market for ophthalmic surgical products in Asia.

 

Report Coverage

This research report categorizes the Japan ophthalmic viscoelastic devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan ophthalmic viscoelastic devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan ophthalmic viscoelastic devices market.

 

Japan Ophthalmic Viscoelastic Devices Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 0.17 Billion
Forecast Period:2023-2033
Forecast Period CAGR 2023-2033 :5.12%
2033 Value Projection:USD 0.28 Billion
Historical Data for:2019-2022
No. of Pages:215
Tables, Charts & Figures:112
Segments covered:By Product, By Application and COVID-19 Impact Analysis
Companies covered:: Baush+Lomb, CIMA Product Inc, RUMEX International Co, ZEISS Group, Bohus BioTech AB, Eyekon Medical, Alcon Inc., Johnson & Johnson, Seikagaku Corporation, Rayner Group., and Others key Vendors
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis.

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

Japan has one of the highest rates of cataract surgeries globally, further boosting the need for advanced ophthalmic surgical devices. Technological advancements in OVD formulations, including the development of high-viscosity, longer-lasting, and biocompatible materials, have enhanced the effectiveness and safety of surgeries, encouraging their adoption. Moreover, increasing awareness of eye health and the rising demand for vision correction among the elderly population have contributed to the market's expansion.

 

Restraining Factors

One of the primary challenges is the high cost associated with advanced OVD formulations, which may limit their affordability, particularly for smaller healthcare facilities or patients without comprehensive insurance coverage.

 

Market Segmentation

The Japan ophthalmic viscoelastic devices market share is classified into product and application.

 

  • The cohesive OVD segment accounted for the largest market share in 2023 and is expected to grow at a remarkable CAGR during the forecast period.

The Japan ophthalmic viscoelastic devices market is segmented by product into cohesive OVD and dispersive OVD. Among these, the cohesive OVD segment accounted for the largest market share in 2023 and is expected to grow at a remarkable CAGR during the forecast period. The segment growth is driven as cohesive OVDs are preferred in ophthalmic surgeries, particularly in cataract procedures, due to their superior ability to maintain eye shape, protect delicate tissues, and provide better control during surgery. These devices are known for their high viscosity and minimal spread, which helps prevent the collapse of the anterior chamber and protects the corneal endothelium.

 

  • The cataract surgery segment accounted for the leading market share in 2023 and is expected to grow at a significant CAGR during the forecast period.

The Japan ophthalmic viscoelastic devices market is segmented by application into cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery. Among these, the cataract surgery segment accounted for the leading market share in 2023 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by the country’s aging population, which has a high prevalence of cataracts. OVDs play a critical role in cataract procedures by maintaining the eye’s shape, protecting the corneal endothelium, and facilitating the implantation of intraocular lenses (IOLs).

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan ophthalmic viscoelastic devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Baush+Lomb
  • CIMA Product Inc
  • RUMEX International Co
  • ZEISS Group
  • Bohus BioTech AB
  • Eyekon Medical
  • Alcon Inc.
  • Johnson & Johnson
  • Seikagaku Corporation
  • Rayner Group.
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan ophthalmic viscoelastic devices market based on the below-mentioned segments:

 

Japan Ophthalmic Viscoelastic Devices Market, By Product

  • Cohesive OVD
  • Dispersive OVD

 

Japan Ophthalmic Viscoelastic Devices Market, By Application

  • Cataract Surgery
  • Glaucoma Surgery
  • Corneal Transplant
  • Vitreoretinal Surgery

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies